Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike NRTIs, it does not mimic nucleosides. Instead, it binds to a distinct allosteric site on the HIV-1 reverse transcriptase enzyme, causing conformational changes that inhibit its activity. This mechanism classifies it clearly as an NNRTI, not an NRTI.